United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read General business news Rushil Decor records robust Q2 FY25 results, eyes expansion with new subsidiary and mega project Rushil Decor Limited has revealed impressive growth in its Q2 FY25 financial performance, showcasing significant gains in revenue… byPallavi MadhirajuOctober 27, 2024